Competing interests
Prostate Cancer, Cancer
PROSTATE CANCER, CANCER
CSL received funding from the National Cancer Institute of the National Institutes of Health (F31CA247093) and the University of California Prostate Cancer Program Pilot Award, was a consultant at Bohn Epidemiology, LLC during the 3-year period surrounding this work, and is currently employed as an Epidemiologist at IQVIA, unrelated to the current study. SAK is a consultant and board member for Fellow Health Inc., unrelated to the current study. JAM has served as an advisor/consultant to Merck Pharmaceutical and COTA Healthcare. No other potential conflicts of interest were reported.